Bloomage BioTechnology Corporation Limited (SHA:688363)

China flag China · Delayed Price · Currency is CNY
51.75
+0.16 (0.31%)
Aug 6, 2025, 1:44 PM CST
0.31%
Market Cap24.68B
Revenue (ttm)5.09B
Net Income (ttm)32.79M
Shares Out478.36M
EPS (ttm)0.07
PE Ratio752.55
Forward PE48.10
Dividend0.11 (0.21%)
Ex-Dividend DateJul 14, 2025
Volume1,534,675
Average Volume3,729,962
Open51.96
Previous Close51.59
Day's Range51.35 - 51.96
52-Week Range42.51 - 84.59
Beta0.74
RSI48.14
Earnings DateAug 27, 2025

About CALT

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under th... [Read more]

Sector Materials
Founded 2000
Employees 4,444
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688363
Full Company Profile

Financial Performance

In 2024, SHA:688363's revenue was 5.37 billion, a decrease of -11.61% compared to the previous year's 6.08 billion. Earnings were 174.27 million, a decrease of -70.59%.

Financial numbers in EUR Financial Statements

News

There is no news available yet.